Search Results

There are 8563 results for: content related to: Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adults

  1. You have free access to this content
    Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa

    British Journal of Clinical Pharmacology

    Volume 80, Issue 1, July 2015, Pages: 146–156, Phumla Z. Sinxadi, Paul D. Leger, Helen M. McIlleron, Peter J. Smith, Joel A. Dave, Naomi S Levitt, Gary Maartens and David W. Haas

    Version of Record online : 28 MAY 2015, DOI: 10.1111/bcp.12590

  2. Mechanism of Efavirenz Influence on Methadone Pharmacokinetics and Pharmacodynamics

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 4, April 2012, Pages: 673–684, E D Kharasch, D Whittington, D Ensign, C Hoffer, P S Bedynek, S Campbell, K Stubbert, A Crafford, A London and T Kim

    Version of Record online : 7 MAR 2012, DOI: 10.1038/clpt.2011.276

  3. Long-Term Efavirenz Autoinduction and Its Effect on Plasma Exposure in HIV Patients

    Clinical Pharmacology & Therapeutics

    Volume 88, Issue 5, November 2010, Pages: 676–684, E Ngaimisi, S Mugusi, O M Minzi, P Sasi, K-D Riedel, A Suda, N Ueda, M Janabi, F Mugusi, W E Haefeli, J Burhenne and E Aklillu

    Version of Record online : 29 SEP 2010, DOI: 10.1038/clpt.2010.172

  4. You have full text access to this OnlineOpen article
    Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 Study

    Clinical Pharmacology & Therapeutics

    Volume 98, Issue 4, October 2015, Pages: 406–416, L Dickinson, J Amin, L Else, M Boffito, D Egan, A Owen, S Khoo, D Back, C Orrell, A Clarke, M Losso, P Phanuphak, D Carey, DA Cooper, S Emery and R Puls2, on behalf of the ENCORE1 Study Group

    Version of Record online : 14 JUL 2015, DOI: 10.1002/cpt.156

  5. Pharmacokinetics of Efavirenz When Co-administered With Rifampin in TB/HIV Co-infected Patients: Pharmacogenetic Effect of CYP2B6 Variation

    The Journal of Clinical Pharmacology

    Volume 48, Issue 9, September 2008, Pages: 1032–1040, Dr Awewura Kwara, Dr Margaret Lartey, Mr Kwamena W. Sagoe, Dr Fafa Xexemeku, Dr Ernest Kenu, Dr Joseph Oliver-Commey, Dr Vincent Boima, Mr Augustine Sagoe, Dr Isaac Boamah, Mr David J. Greenblatt and Dr Michael H. Court

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008321790

  6. You have free access to this content
    CYP2B6 (c.516G[RIGHTWARDS ARROW]T) and CYP2A6 (*9B and/or *17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV-infected patients

    British Journal of Clinical Pharmacology

    Volume 67, Issue 4, April 2009, Pages: 427–436, Awewura Kwara, Margaret Lartey, Kwamena W. Sagoe, Naser L. Rzek and Michael H. Court

    Version of Record online : 21 JAN 2009, DOI: 10.1111/j.1365-2125.2009.03368.x

  7. You have full text access to this OnlineOpen article
    Towards a Best Practice Approach in PBPK Modeling: Case Example of Developing a Unified Efavirenz Model Accounting for Induction of CYPs 3A4 and 2B6

    CPT: Pharmacometrics & Systems Pharmacology

    Volume 5, Issue 7, July 2016, Pages: 367–376, A Ke, Z Barter, K Rowland-Yeo and L Almond

    Version of Record online : 20 JUL 2016, DOI: 10.1002/psp4.12088

  8. You have free access to this content
    A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single-dose efavirenz population pharmacokinetics in Ugandans

    British Journal of Clinical Pharmacology

    Volume 68, Issue 5, November 2009, Pages: 690–699, Jackson K. Mukonzo, Daniel Röshammar, Paul Waako, Maria Andersson, Takashi Fukasawa, Lili Milani, Jan Olof Svensson, Jasper Ogwal-Okeng, Lars L. Gustafsson and Eleni Aklillu

    Version of Record online : 7 AUG 2009, DOI: 10.1111/j.1365-2125.2009.03516.x

  9. You have free access to this content
    Neuropsychometric correlates of efavirenz pharmacokinetics and pharmacogenetics following a single oral dose

    British Journal of Clinical Pharmacology

    Volume 75, Issue 4, April 2013, Pages: 997–1006, Daniel H. Johnson, Tebeb Gebretsadik, Ayumi Shintani, Gail Mayo, Edward P. Acosta, C. Michael Stein and David W. Haas

    Version of Record online : 15 MAR 2013, DOI: 10.1111/j.1365-2125.2012.04454.x

  10. Effect of Rifampicin and CYP2B6 Genotype on Long-Term Efavirenz Autoinduction and Plasma Exposure in HIV Patients With or Without Tuberculosis

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 3, September 2011, Pages: 406–413, E Ngaimisi, S Mugusi, O Minzi, P Sasi, K-D Riedel, A Suda, N Ueda, M Janabi, F Mugusi, W E Haefeli, L Bertilsson, J Burhenne and E Aklillu

    Version of Record online : 3 AUG 2011, DOI: 10.1038/clpt.2011.129

  11. You have free access to this content
    In silico prediction of efavirenz and rifampicin drug–drug interaction considering weight and CYP2B6 phenotype

    British Journal of Clinical Pharmacology

    Volume 71, Issue 4, April 2011, Pages: 536–543, Dinko Rekić, Daniel Röshammar, Jackson Mukonzo and Michael Ashton

    Version of Record online : 11 MAR 2011, DOI: 10.1111/j.1365-2125.2010.03883.x

  12. Novel CYP2B6 Enzyme Variants in a Rwandese Population: Functional Characterization and Assessment of In Silico Prediction Tools

    Human Mutation

    Volume 34, Issue 5, May 2013, Pages: 725–734, Robert Radloff, Alain Gras, Ulrich M. Zanger, Cécile Masquelier, Karthik Arumugam, Jean-Claude Karasi, Vic Arendt, Carole Seguin-Devaux and Kathrin Klein

    Version of Record online : 11 MAR 2013, DOI: 10.1002/humu.22295

  13. Evaluation of 227 Drugs for In Vitro Inhibition of Cytochrome P450 2B6

    The Journal of Clinical Pharmacology

    Volume 46, Issue 12, December 2006, Pages: 1426–1438, Robert L. Walsky, Angela V. Astuccio and R. Scott Obach

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006293753

  14. You have free access to this content
    Differential activation of human constitutive androstane receptor and its SV23 and SV24 splice variants by rilpivirine and etravirine

    British Journal of Pharmacology

    Volume 172, Issue 5, March 2015, Pages: 1263–1276, Devinder Sharma, Aik Jiang Lau, Matthew A Sherman and Thomas K H Chang

    Version of Record online : 10 FEB 2015, DOI: 10.1111/bph.12997

  15. Compartment-Specific Gene Regulation of the CAR Inducer Efavirenz In Vivo

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 1, July 2012, Pages: 103–111, H E Meyer zu Schwabedissen, S Oswald, C Bresser, A Nassif, C Modess, Z Desta, E T Ogburn, M Marinova, D Lütjohann, C Spielhagen, M Nauck, H K Kroemer and W Siegmund

    Version of Record online : 16 MAY 2012, DOI: 10.1038/clpt.2012.34

  16. You have free access to this content
    Effects of clopidogrel and itraconazole on the disposition of efavirenz and its hydroxyl metabolites: exploration of a novel CYP2B6 phenotyping index

    British Journal of Clinical Pharmacology

    Volume 75, Issue 1, January 2013, Pages: 244–253, Fen Jiang, Zeruesenay Desta, Ji-Hong Shon, Chang-Woo Yeo, Ho-Sook Kim, Kwang-Hyeon Liu, Soo-Kyung Bae, Sang-Seop Lee, David A. Flockhart and Jae-Gook Shin

    Version of Record online : 14 DEC 2012, DOI: 10.1111/j.1365-2125.2012.04314.x

  17. You have full text access to this OnlineOpen article
    Dose Optimization of Efavirenz Based on Individual CYP2B6 Polymorphisms in Chinese Patients Positive for HIV

    CPT: Pharmacometrics & Systems Pharmacology

    Volume 5, Issue 4, April 2016, Pages: 182–191, KH Hui, SS Lee and TN Lam

    Version of Record online : 6 APR 2016, DOI: 10.1002/psp4.12067

  18. You have full text access to this OnlineOpen article
    The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children

    British Journal of Clinical Pharmacology

    Volume 82, Issue 1, July 2016, Pages: 185–198, Andrzej Bienczak, Adrian Cook, Lubbe Wiesner, Adeniyi Olagunju, Veronica Mulenga, Cissy Kityo, Addy Kekitiinwa, Andrew Owen, A. Sarah Walker, Diana M. Gibb, Helen McIlleron, David Burger and Paolo Denti

    Version of Record online : 25 APR 2016, DOI: 10.1111/bcp.12934

  19. Pharmacokinetic Interaction Between Efavirenz and Carbamazepine After Multiple-Dose Administration in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 48, Issue 8, August 2008, Pages: 948–956, Ping Ji, Dr Bharat Damle, Dr Jingdong Xie, Dr Steve E. Unger, Dennis M. Grasela and Sanjeev Kaul

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008319792

  20. You have free access to this content
    Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism

    British Journal of Clinical Pharmacology

    Volume 61, Issue 2, February 2006, Pages: 148–154, David Burger, Ilse Van Der Heiden, Charles La Porte, Marchina Van Der Ende, Paul Groeneveld, Clemens Richter, Peter Koopmans, Frank Kroon, Herman Sprenger, Jan Lindemans, Paul Schenk and Ron Van Schaik

    Version of Record online : 11 NOV 2005, DOI: 10.1111/j.1365-2125.2005.02536.x